Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121747414 | 12174741 | 4 | F | 20160902 | 20160314 | 20160914 | EXP | JP-UCBSA-2016008165 | UCB | 85.00 | YR | F | Y | 0.00000 | 20160914 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121747414 | 12174741 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Intravenous drip | 500 MG, ONCE DAILY (QD) | Y | U | 21035 | 500 | MG | QD | |||||
| 121747414 | 12174741 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Y | U | 21035 | ||||||||||
| 121747414 | 12174741 | 3 | SS | Nobelbar | PHENOBARBITAL SODIUM | 1 | Intravenous (not otherwise specified) | 250 MG | Y | U | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121747414 | 12174741 | 1 | Status epilepticus |
| 121747414 | 12174741 | 2 | Off label use |
| 121747414 | 12174741 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121747414 | 12174741 | OT |
| 121747414 | 12174741 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121747414 | 12174741 | Coma | |
| 121747414 | 12174741 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |